Priority Date: 23.02.12 (JP 20120037448)

COMBINED ANTICANCER DRUG SENSITIVITY-DETERMINING MARKER

  • Application ID: EP13752246
  • Status: GRANT OF PATENT INTENDED

Applicants

Research organisation logo small
Research Organisation
Technology company logo small
Technology Company

Attorney

operating since 1970
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING). We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Engel Patentanwaltskanzlei, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 172 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 23.02.2012 - Priority Date (JP 20120037448)
  • 29.08.2013 - Publication A1 (WO2013125675)
  • 31.12.2014 - Publication A1 (EP2818870)